Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

NCT05854069 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05854069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05854069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 30, 2023
Completion date
April 30, 2027
Enrollment
140 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes